AI Infrastructure: Beyond Oracle's Historic Deal
Oracle's historic $300 billion deal to provide OpenAI with massive computing power highlights the surging demand for AI infrastructure. This creates a significant investment opportunity in the companies building the essential components for next-generation data centers.
Top Picks from This Group
Here are a few of the assets in this group. Create an account to unlock the full list.
Join Nemo FREE today and unlock every stock
It only takes 60 seconds.
12 Month Growth Potential
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitive Ltd.
If you invested across these assets:
In 12 months it might be worth:
+398.49%
About This Group of Stocks
Our Expert Thinking
Oracle's landmark $300 billion deal with OpenAI represents a seismic shift in AI infrastructure investment. This massive commitment to cloud compute capacity signals unprecedented demand for the foundational components that power next-generation data centres, creating a powerful ripple effect throughout the entire technology supply chain.
What You Need to Know
This group focuses on companies essential to the AI data centre ecosystem, from semiconductor giants and memory chip manufacturers to networking equipment specialists and power infrastructure providers. These businesses are positioned to benefit from the massive capital expenditures flowing into AI infrastructure as demand for computing power continues to surge.
Why These Stocks
Each company in this collection was handpicked by professional analysts for their strategic role in supporting the AI infrastructure build-out. These firms represent key players across the entire value chain, from the processors and memory that power AI workloads to the networking and power systems that keep these energy-intensive facilities running.
Group Performance Snapshot
Average 12 Month Profit
On average, analysts expect assets in this group to grow 398.49% over the next year.
Stocks Rated Buy by Analysts
11 of 14 assets in this group are rated Buy by professional analysts.
Why You'll Want to Watch These Stocks
Historic Investment Wave
Oracle's $300 billion commitment to OpenAI represents one of the largest infrastructure deals in tech history. This unprecedented investment signals a massive shift in how companies are prioritising AI capabilities.
Supply Chain Goldmine
The ripple effects from this mega-deal could benefit every company in the AI infrastructure chain. From chip makers to power suppliers, the entire ecosystem stands to gain from this surge in demand.
Perfect Timing Play
You're getting in as the AI infrastructure boom is just beginning. With more companies racing to secure computing power, these foundational businesses could see sustained growth for years to come.
Get the full story on this Basket. Read our detailed article on its risks and potential.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Fed Pivot Play: Financial Sector's Risk-Reward Trade
An unexpected drop in wholesale prices has increased the likelihood that the Federal Reserve will cut interest rates to support the economy. This potential shift in monetary policy creates opportunities for companies in sectors that are sensitive to lower borrowing costs, such as banking and financial services.
Financial Giants (JPM, GS, V, MA) Investment Guide
As Africa's economic landscape matures, its ties to the world's leading financial institutions are deepening. This basket offers exposure to a selection of these global financial giants, including investment banks and payment innovators with a strategic footprint on the continent.
Pharma Investment Basket Explained (Eli Lilly+)
Nigeria's growing population is increasingly seeking exposure to global health advancements, particularly from leading pharmaceutical innovators. This basket provides potential exposure to this trend through a collection of US and EU-listed pharmaceutical, biotechnology, and healthcare supply chain companies.
Frequently Asked Questions
Everything you need to know about the product and billing.